newsfilter
← Latest News
GlobeNewswire·

Tryp Therapeutics Announces Fiscal Year 2022 Financial Results and Reports Corporate Highlights

KELOWNA, British Columbia, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Tryp Therapeutics, Inc. (CSE:TRYP) (OTCQB:TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active